Movement disorders: Phase II trials

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Nelotanserin

Phase II

Dementia; Parkinsons; hallucinations; sleep behaviour disorder

United States

Recruiting (invitation only)

https://clinicaltrials.gov/ct2/show/NCT02871427?term=sleep&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=3


Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

PF-06649751

Phase II

Parkinsons

Ongoing, not yet recruiting

https://clinicaltrials.gov/ct2/show/NCT02847650?term=parkinsons&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=1


ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

ADX48621

Phase II

Parkinson's disease

USA, France, Austria, Germany

Completed

Click here for further information


Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin

Intranasal Insulin

Phase II

United States

Recruiting

Click here for further information


Deep Brain Stimulation for Cervical Dystonia

Deep Brain Stimulation

Phase II

United States

Completed

Click here for further information